Younger age, substance use, and HCC may be risk factors for repeat HCV viremia in patients who achieve SVR following DAA therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback